Our Management Team leverages their deep industry experience, data-driven insights and strategic innovation to empower our team of advocates who deliver novel healthcare solutions that help customers succeed in an increasingly challenging business climate.
Chief Operating Officer & Chief Financial OfficerShow Bio
Andy Kitzmiller joined Meridian in February 2022 as Executive Vice President and Chief Financial Officer, where oversees the global finance organization and financial activities, including financial planning and analysis, accounting and controllership, tax, internal audit, and treasury. As of April 2023, Andy is the Chief Operating Officer & Chief Financial Officer. Before Meridian, Andy was Vice President, Chief Accounting Officer, and Corporate Controller for Hillenbrand, Inc. In that role, Andy was responsible for all external and internal financial reporting, internal controls over financial reporting, and supported the annual budgeting, periodic forecasting, and quarterly earnings guidance processes. Andy also supported all of Hillenbrand’s corporate development activity since the acquisition of Milacron by Hillenbrand, served on various committees within Hillenbrand, and was a strategic partner to the six operating companies within Hillenbrand. Before Hillenbrand, Andy was the Vice President of Finance and Corporate Controller of Milacron, spent five years in various global finance roles at GE Aviation, and spent ten years in the audit practice of Deloitte & Touche in Cincinnati.
President, DiagnosticsShow Bio
Tony Serafini-Lamanna is a highly accomplished and respected leader with over 30 years of experience in the healthcare diagnostics industry. Throughout his career, Tony has held various leadership roles and is widely recognized for his expertise in driving commercial excellence and developing strategic plans that deliver results. In 2018, Tony joined Meridian Bioscience as Vice President and General Manager of the Diagnostics business unit. In this role, he was instrumental in developing and executing the Diagnostics strategic plan, resulting in significant growth for the company. Tony's expertise in mobilizing marketing, technical services, and commercial operations drove commercial excellence, and he was also responsible for driving new product development and the successful acquisition and integration of three companies. Due to his exceptional contributions, Tony was promoted to Executive Vice President, Diagnostics in May 2020. In this expanded role, he oversaw the Diagnostics division’s business operations, making significant contributions to the success of the division. In April 2023, Tony was appointed President of Diagnostics, now with ownership of the division’s P&L. This appointment is a testament to his leadership and expertise in the field. Prior to joining Meridian, Tony served as General Manager and led commercial operations and global marketing for Siemens Healthineers, where he played a significant role in the company's growth and success. Tony is known for his strategic thinking, leadership skills, and passion for driving results. He is committed to working collaboratively with his team to achieve shared goals and make a positive impact on the healthcare industry.
President, Life ScienceShow Bio
Dr. Lourdes G. Weltzien is an accomplished leader with 30 years of experience in the Life Science and Diagnostic industry. She joined Meridian in July 2008 as General Manager for the Life Science business, and since then, she has held various leadership positions in the company. In September 2013, she was appointed Vice President, and in July 2016, she became President of Asia Pacific Markets, where she was responsible for driving growth and expanding Meridian's presence in the region. In March 2018, Dr. Weltzien was promoted to Executive Vice President, overseeing Meridian's Life Science business, which consists of raw materials for the development and manufacturing of molecular and immunological assays. In this role, she has been instrumental in developing and executing strategies that have resulted in significant growth and improved profitability for the company. In recognition of her outstanding leadership and contributions to the company, Dr. Weltzien was appointed President of Meridian's Life Science business in April 2023. Her extensive experience, strategic vision, and passion for innovation will continue to drive Meridian's growth and success in the years ahead. Prior to joining Meridian, Dr. Weltzien held several President, Vice President, and General Manager positions at Sigma-Aldrich Corporation (now Millipore-Sigma) since 1994. During her tenure, she managed full P&L responsibilities in Manufacturing, Operations, Sales, Marketing, R&D, and Product Management in North America and Europe.
Emerson C. Moser
Senior Vice President and General CounselShow Bio
Emerson Moser joined Meridian in October 2022 as Senior Vice President and General Counsel. He heads the legal department at Meridian, providing business and legal counsel to the executive leadership team and advising the Company on all legal matters, including mergers and acquisitions, commercial agreements, compliance, litigation, and data privacy. Emerson has significant prior in-house legal experience, having served as General Counsel to Hillenbrand, Inc.’s Milacron group of businesses and as Sr. Vice President, General Counsel, and Corporate Secretary for General Cable Corporation. Emerson began his career in private practice with the law firm, Dinsmore & Shohl LLP, and then served as Assistant General Counsel of NIBCO, INC. He received his law degree from Wake Forest University and undergraduate degrees in Economics and Political Science from Purdue University.
Vice President, Global Human ResourcesShow Bio
Melissa McCarey was appointed Global Vice President of Human Resources in April of 2018. She is responsible for all human resource members across Meridian’s international sites. Ms. McCarey joined Meridian from Ortho Clinical Diagnostics where she was the Director of HR for North America Commercial Operations. Prior to her tenure at Ortho, she spent 15 years at Siemens Healthcare in various HR leadership positions.
Vice President, Strategy & Corporate DevelopmentShow Bio
Charlie Wood joined in January of 2020 as Vice President of Corporate Strategy, Business Development, and Investor Relations. He joined Meridian from Thornburgh & Peterson, where he was advising small to medium businesses on strategic finance, growth strategy, mergers, acquisitions, and partnerships. Prior to Thornburgh & Peterson, Mr. Wood held various leadership roles in Corporate Development, Strategy, and Finance at AT&T and Electronic Arts.